Hydrochloric Acid → (S)-2-(4-(3-(4-fluorophenyl)-1H-1,2,4-triazol-1-yl)phenyl)morpholine hydrochloride
反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[CH:11][N:10]([C:13]3[CH:18]=[CH:17][C:16]([C@@H:19]4[O:24][CH2:23][CH2:22][N:21](C(OC(C)(C)C)=O)[CH2:20]4)=[CH:15][CH:14]=3)[N:9]=2)=[CH:4][CH:3]=1.[ClH:32].CCOCC>O1CCOCC1>[ClH:32].[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[CH:11][N:10]([C:13]3[CH:14]=[CH:15][C:16]([C@@H:19]4[O:24][CH2:23][CH2:22][NH:21][CH2:20]4)=[CH:17][CH:18]=3)[N:9]=2)=[CH:4][CH:3]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 60 °C
実験手順
(S)-tert-butyl 2-(4-(3-(4-fluorophenyl)-1H-1,2,4-triazol-1-yl)phenyl)morpholine-4-carboxylate (201 mg, 0.47 mmol) was dissolved in dioxane (0.5 ml) and a solution of HCl in dioxane (4M, 1.75 ml, 7.1 mmol) was added. The reaction mixture was stirred for 3 h at 60° C. After cooling ether (2 ml) was added and the solid was filtered off. It was washed with ether and dried in vacuo to afford (S)-2-(4-(3-(4-fluorophenyl)-1H-1,2,4-triazol-1-yl)phenyl)morpholine hydrochloride as a white solid (170 mg, 99%). MS (ISP): 325.2 ([M+H]+).
後処理
- additionwas added
- filtrationthe solid was filtered off
- washIt was washed with ether
- customdried in vacuo
出典と根拠
- ORDレコード
- ord-518d85b4070a4f1fb171c58040d02b60
- 出典データセット
- uspto-grants-2015_11
- 特許番号
- US09181230B2
反応ノート
読み込み中…